US2014350254A1PendingUtilityA1

Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders

Assignee: ALKERMES PHARMA IRELAND LTDPriority: Jun 25, 2009Filed: Jun 5, 2014Published: Nov 27, 2014

Est. expiryJun 25, 2029(~2.9 yrs left)· nominal 20-yr term from priority

Inventors:Julius F. Remenar Laura Cook Blumberg Tarek A. Zeidan

A61P 43/00A61P 25/16A61P 25/20A61P 25/22A61P 25/00A61P 25/28A61P 25/18A61P 25/24C07D 413/10C07F 9/65583A61K 31/497C07D 413/14C07D 417/14C07D 241/04C07D 263/58C07D 215/227C07D 401/12C07D 401/14C07F 9/6558C07D 215/22C07D 417/12A61K 31/496C07D 471/04

PatentIndex Score

Cited by

References

Claims

Abstract

Lactam compounds of Formula I and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia is disclosed.

Claims

exact text as granted — not AI-modified

1 - 34 . (canceled) 
     
     
         35 . A compound of formula: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         36 . A compound of formula: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         37 . A compound of formula: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2014350254A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.